Regulatory
An In-Depth Review of AAHP’s 2021 Summit
By Eric L. Foxman, Pharmacist, AAHP Secretary Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts that will be important to manufacturers and marketers in the coming months and years. But first a huge thank you readm more…
Read MoreSuccess: Implementing HPUS Guidelines for FDA Compliance, Part 2
By Mark Land, AAHP President Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives. This was the second installment of a compliance program being developed by the Homeopathic Pharmacopoeia Convention of the United States readm more…
Read MoreInternational Coalition of Homeopathic Associations
By Mark Land, AAHP President David Skinner of the Canadian Homeopathic Pharmaceutical Association recently wrote that there is a need for an international coalition of homeopathic associations. He makes this recommendation based the perceived need to monitor and respond to the international implications of actions taken by individual regulators. David readm more…
Read MoreHomeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted that over the past 12 months, the HPCUS held almost 40 meetings; the pandemic circumstances forced all to be held readm more…
Read MoreThe Environment for Homeopathy in Canada
By David Skinner, Association Manager, Canadian Homeopathic Pharmaceutical Association In the global context, Canada is a very small market, but the dynamics are no different than in other large markets like the United States. Above the 49th parallel, there are professional critics of all things falling outside the modern science readm more…
Read More117th Congress and Biden Administration Underway
By Pete Evich, AAHP Government Affairs On Jan. 20, Joe Biden was sworn in as the 46th President of the United States. On the same day, both of Georgia’s newly elected Democratic Senators were also sworn into the U.S. Senate. These events put the Democrats in control of both readm more…
Read More2020 Presidential & Congressional Elections: Outcome and Agenda Outlook in the 117th Congress
By Pete Evich, AAHP Regulatory Affairs Presidency and Congress President-elect Joe Biden managed to defeat an incumbent president — the first time that’s happened in 28 years. Sen. Kamala Harris made history as the first woman, first Black person, and first South Asian American person to be elected vice readm more…
Read MoreHow Real-World Data Is Impacting Health Care Decisions Today
By Mark Land, AAHP President I have been interested in the application of Real-World Data (RWD) and Real-World Evidence (RWE) for some time now. Originally, I confused RWD and RWE with Patient Centered Data (PCD). In doing so, I thought that patient-supplied evaluation, such as Quality of Life, Compliance, and readm more…
Read MoreHomeopathic Process Validation for Beginners
Consistent, effective, high-quality homeopathic products. That’s what our consumers want in each and every dose. Yet quality doesn’t happen by accident. Manufacturers must create it through process validation. Each manufacturer must ask themselves: Do I have scientific evidence that my (manufacturing) process is capable of reliably delivering quality product? readm more…
Read MoreCOVID-19 CARES Act Aids Availability of OTC Products
On March 27, President Trump signed into law the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). This landmark legislation provides financial relief for workers, small businesses, and healthcare professionals affected by the coronavirus…
Read More